183 related articles for article (PubMed ID: 28738277)
1. New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: Playing with auxiliary ligands for tuning the mechanism of biological activity.
Łomzik M; Mazuryk O; Rutkowska-Zbik D; Stochel G; Gros PC; Brindell M
J Inorg Biochem; 2017 Oct; 175():80-91. PubMed ID: 28738277
[TBL] [Abstract][Full Text] [Related]
2. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
[TBL] [Abstract][Full Text] [Related]
3. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.
Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T
Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II) complexes as mitochondrial inhibitors of topoisomerase induced A549 cell apoptosis.
Tang H; Guo X; Yu W; Gao J; Zhu X; Huang Z; Ou W; Zhang H; Chen L; Chen J
J Inorg Biochem; 2023 Sep; 246():112295. PubMed ID: 37348172
[TBL] [Abstract][Full Text] [Related]
7. Near-IR/Visible-Emitting Thiophenyl-Based Ru(II) Complexes: Efficient Photodynamic Therapy, Cellular Uptake, and DNA Binding.
Zhang SQ; Meng TT; Li J; Hong F; Liu J; Wang Y; Gao LH; Zhao H; Wang KZ
Inorg Chem; 2019 Oct; 58(20):14244-14259. PubMed ID: 31595752
[TBL] [Abstract][Full Text] [Related]
8. Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance.
Wei L; He X; Zhao D; Kandawa-Shultz M; Shao G; Wang Y
Eur J Med Chem; 2024 Jan; 264():115985. PubMed ID: 38016298
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF
Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
11. 8-Hydroxyquinoline-modified ruthenium(II) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy.
Ma X; Lu J; Yang P; Zhang Z; Huang B; Li R; Ye R
Dalton Trans; 2022 Sep; 51(36):13902-13909. PubMed ID: 36040403
[TBL] [Abstract][Full Text] [Related]
12. The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.
Chen L; Li G; Peng F; Jie X; Dongye G; Cai K; Feng R; Li B; Zeng Q; Lun K; Chen J; Xu B
Oncotarget; 2016 Dec; 7(49):80716-80734. PubMed ID: 27811372
[TBL] [Abstract][Full Text] [Related]
13. The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Mazuryk O; Suzenet F; Kieda C; Brindell M
Metallomics; 2015 Mar; 7(3):553-66. PubMed ID: 25711770
[TBL] [Abstract][Full Text] [Related]
14. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes.
Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y
Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
[TBL] [Abstract][Full Text] [Related]
16. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
[TBL] [Abstract][Full Text] [Related]
17. Unexplored features of Ru(ii) polypyridyl complexes - towards combined cytotoxic and antimetastatic activity.
Gurgul I; Mazuryk O; Łomzik M; Gros PC; Rutkowska-Zbik D; Brindell M
Metallomics; 2020 May; 12(5):784-793. PubMed ID: 32227043
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer evaluation of novel half-sandwich Ru(II) complexes bearing pyrazalone moiety: Apoptosis inducers based on mitochondrial dysfunction and G0/G1 arrest.
Huang Y; Huang S; Wei W; Wu Y; Jia L; Du Y; Luo P; Pan W
J Inorg Biochem; 2024 Jan; 250():112421. PubMed ID: 37922609
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells.
Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y
J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581
[TBL] [Abstract][Full Text] [Related]
20. A ruthenium(II) complex containing a p-cresol group induces apoptosis in human cervical carcinoma cells through endoplasmic reticulum stress and reactive oxygen species production.
Xu L; Zhang PP; Fang XQ; Liu Y; Wang JQ; Zhou HZ; Chen ST; Chao H
J Inorg Biochem; 2019 Feb; 191():126-134. PubMed ID: 30508750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
